Drug intelligence / Profile preview

FA-PAMAMG2-MCS

Development stage
Preclinical
Lead developer
Islamic Azad University
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

FA-PAMAMG2-MCS is a multifunctional, magnetic, and pH-responsive nanocarrier developed for the targeted delivery and controlled release of chemotherapeutic agents, specifically doxorubicin (DOX). Synthesized by researchers at Islamic Azad University, the nanocomposite is fabricated by grafting a generation 2 poly(amidoamine) (PAMAM G2) dendrimer and folic acid (FA) onto a magnetic chitosan (MCS) core-shell surface. The folic acid moiety enables active targeting of folate receptors, which are frequently overexpressed on cancer cells, such as the human breast cancer cell line MDA-MB-231. The magnetic chitosan core provides superparamagnetic properties, allowing for potential magnetic-field-directed targeting, while the pH-sensitive nature of the nanocarrier facilitates accelerated drug release in acidic tumor microenvironments compared to neutral physiological conditions.

Other names
FA-PAMAM G2-MCSFA-PAMAM-G2-MCSFA-PAMAM-G-2-MCSFA-PAMAM-G 2-MCSfolic acid conjugated poly(amidoamine) dendrimer grafted magnetic chitosanfolic acid-conjugated poly(amidoamine) dendrimer-grafted magnetic chitosan
02

Targets

FOLR1 (FRα)FOLR2 (Folate receptor beta)TOP2A (DNA topoisomerase II)FOLR3 (Folate receptor gamma)

Beyond the preview

Go deeper on FA-PAMAMG2-MCS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FA-PAMAMG2-MCS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call